Jurado-Ruiz Enrique, Varela Lourdes M, Luque Amparo, Berná Genoveva, Cahuana Gladys, Martinez-Force Enrique, Gallego-Durán Rocío, Soria Bernat, de Roos Baukje, Romero Gómez Manuel, Martín Franz
Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Universidad Pablo Olavide, Seville, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600549. Epub 2016 Dec 13.
We evaluated the protective effect of extra virgin olive oil (EVOO) in high-fat diets (HFDs) on the inflammatory response and liver damage in a nonalcoholic fatty liver disease (NAFLD) mouse model.
C57BL/6J mice were fed a standard diet or a lard-based HFD (HFD-L) for 12 wk to develop NAFLD. HFD-fed mice were then divided into four groups and fed for 24 wk with the following: HFD-L, HFD-EVOO, HFD based on phenolics-rich EVOO, and reversion (standard diet). HFD-L-induced metabolic disorders were alleviated by replacement of lard with EVOO. EVOO diets improved plasma lipid profile and reduced body weight, plasma and epididymal fat INF-γ, IL-6 and leptin levels, and macrophage infiltration. Moreover, NAFLD activity scores were reduced. The liver lipid composition showed an increase in MUFAs, especially oleic acid, and a decrease in saturated fatty acids. Hepatic adiponutrin and Cd36 gene expression was upregulated in the EVOO groups. Liver ingenuity pathway analysis revealed in EVOO groups regulation of proteins involved in lipid metabolism, small molecule biochemistry, gastrointestinal disease, and liver regeneration.
Dietary EVOO could repair HFD-induced hepatic damage, possibly via an anti-inflammatory effect in adipose tissue and modifications in the liver lipid composition and signaling pathways.
我们评估了特级初榨橄榄油(EVOO)在高脂饮食(HFD)中对非酒精性脂肪性肝病(NAFLD)小鼠模型炎症反应和肝损伤的保护作用。
将C57BL/6J小鼠喂食标准饮食或基于猪油的高脂饮食(HFD-L)12周以诱导NAFLD。然后将喂食高脂饮食的小鼠分为四组,并分别喂食以下饮食24周:HFD-L、HFD-EVOO、基于富含酚类物质的EVOO的高脂饮食以及恢复饮食(标准饮食)。用EVOO替代猪油可减轻HFD-L诱导的代谢紊乱。EVOO饮食改善了血浆脂质谱,降低了体重、血浆和附睾脂肪中的INF-γ、IL-6和瘦素水平以及巨噬细胞浸润。此外,NAFLD活动评分降低。肝脏脂质组成显示单不饱和脂肪酸增加,尤其是油酸,饱和脂肪酸减少。EVOO组肝脏中脂肪营养蛋白和Cd36基因表达上调。肝脏通路分析显示,EVOO组中参与脂质代谢、小分子生物化学、胃肠道疾病和肝脏再生的蛋白质受到调控。
膳食EVOO可能通过对脂肪组织的抗炎作用以及肝脏脂质组成和信号通路的改变来修复HFD诱导的肝损伤。